Our experimental model where eNOS activity was impaired by pharmacological and genetic inhibition may represent a good in vitro system to study the effect of NO deficiency on vascular endothelial cells, and to find new therapeutic target (HIF-1α protein for example) possibly useful for treating endothelial dysfunction. This evidence concerns the gene HIF1A and endothelial dysfunction.